Shares of GSK plc (NYSE:GSK – Get Free Report) have been given an average rating of “Moderate Buy” by the ten research firms ...

The user of the website is referred to as "you" and "your". By posting on our share chat boards you are agreeing to the following: If you are going to post non-English, please also post an English ...

Though GSK is definitely not the best large-cap drugmaker to have in one's portfolio, we believe there is potential for its ...

The main aim of stock picking is to find the market-beating stocks. But the main game is to find enough winners to ...

The GSK share price rose slightly after the company announced positive result for its linerixibat, a drug that will be used to treat relentless itching caused by primary biliary cholangitis (PBC).

Analysts at Zacks Research reduced their Q1 2026 EPS estimates for shares of GSK in a research note issued to investors on ...

The GSK (GSK.L) share price has fallen off its perch. So it may be a good time to research and consider the stock opportunity. I think the global biopharma company has been dripping with promise for a ...

GSK plc stock is downgraded due to litigation risks, weak sales, and market pressures, dividend yield remains a bright spot. Click for more on GSK stock.